Controlled release systems containing solid dispersions: Strategies and mechanisms

Pharmaceutical Research

Volumn 28, Issue 10, 2011, Pages 2353-2378

  Tran, Phuong Ha Lien ^a   Tran, Thao Truong Dinh ^a   Park, Jun Bom ^a   Lee, Beom Jin ^a  

^a Kangwon National University   (South Korea)

Author keywords

controlled release solid dispersion; manufacturing methods; physicochemical characterization; poorly water soluble drugs; rate controlling mechanism

Indexed keywords

ACECLOFENAC; DIPYRIDAMOLE; FELODIPINE; FLURBIPROFEN; FUROSEMIDE; INDOMETACIN; NAPROXEN; NILVADIPINE; NIMODIPINE; NITRENDIPINE;

CHEMICAL PROCEDURES; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED RELEASE SOLID DISPERSION; CRYSTALLIZATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG SOLUBILITY; HOT MELT EXTRUSION; HYDROPHILICITY; HYDROPHOBICITY; MELTDOSE; MISCIBILITY; MOLECULAR INTERACTION; NON SELF EMULSIFYING SOLID DISPERSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUASI EMULSION SOLVENT DIFFUSION METHOD; REVIEW; SELF EMULSIFYING SOLID DISPERSION; SOLVENT EFFECT; TABLET COMPRESSION; TABLET HARDNESS; VISCOSITY;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 80054725610     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0449-y     Document Type: Review

References (189)

1. PD Haan CF Lerk 1984 Oral controlled release dosage forms. A review Pharm World Sci 6 2 57 67 (Pubitemid 14103260)
2. T Salsa F Veiga ME Pina 1997 Oral controlled-release dosage forms. I. cellulose ether polymers in hydrophilic matrices Drug Dev Ind Pharm 23 9 929 938 1:CAS:528:DyaK2sXmtF2qsLc%3D (Pubitemid 27406365)
3. N Tanaka K Imai K Okimoto S Ueda Y Tokunaga R Ibuki, et al. 2006 Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation J Control Release 112 1 51 56 16545477 1:CAS:528:DC%2BD28XjsFarsL8%3D
4. LN Sansom 1999 Oral extended-release products Aust Prescr 22 88 90 (Pubitemid 29450725)
5. N Tanaka K Imai K Okimoto S Ueda Y Tokunaga A Ohike, et al. 2005 Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine J Control Release 108 2-3 386 395 16253377 1:CAS:528:DC%2BD2MXht1aiu7fP (Pubitemid 41608670)
6. WL Chiou S Riegelman 1971 Pharmaceutical applications of solid dispersions J Pharm Sci 60 9 1281 1302 4935981 1:STN:280:DyaE3M3otFersQ%3D%3D
7. JL Ford 1986 The current status of solid dispersions Pharm Acta Helv 61 3 69 88 3520598 1:CAS:528:DyaL28XhvFaqtb4%3D (Pubitemid 16134014)
8. DQM Craig 1990 Polyethylene glycols and drug release Drug Dev Ind Pharm 16 17 2501 2526 1:CAS:528:DyaK3MXivF2ruw%3D%3D
9. ATM Serajuddin 1999 Solid dispersions of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J Pharm Sci 88 10 1058 1066 10514356 1:CAS:528:DyaK1MXltl2jtbk%3D
10. DQM Craig 2002 The mechanisms of drug release from solid dispersions in water-soluble polymers Int J Pharm 231 2 131 144 11755266 1:CAS:528: DC%2BD3MXptlaitL0%3D (Pubitemid 34033673)
11. T Ozeki H Yuasa Y Kanaya 1997 Application of the solid dispersion method to the controlled release of medicine: IX. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxypropylcellulose and the interaction between medicine and polymers Int J Pharm 155 2 209 217 1:CAS:528:DyaK2sXmsFGksbo%3D (Pubitemid 27380407)
12. M Yang F Cui B You L Wang P Yue Y Kawashima 2004 A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system Int J Pharm 286 1-2 99 109 15501006 1:CAS:528:DC%2BD2cXovVSktr4%3D (Pubitemid 39410477)
13. Kerč J. Three-phase pharmaceutical form-threeform-with controlled release of amorphous active ingredient for once-daily administration. In: Rathbone MJ, Hadgraft J, Roberts MS, editors. Modified-release drug delivery technology, drugs and the pharmaceutical sciences vol. 126. New York: Marcel Dekker; 2003. p. 115-23.
14. TT-D Tran PH-L Tran J-S Lim J-B Park S-K Choi B-J Lee 2010 Physicochemical principles of controlled release solid dispersion containing a poorly water-soluble drug Therapeutic Delivery 1 1 51 62 1:CAS:528: DC%2BC3cXpvFOmtLY%3D
15. Habib MJ. Pharmaceutical solid dispersion technology. Lancaster: Technomic Pub. Co.; 2001.
16. T Vasconcelos B Sarmento P Costa 2007 Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov Today 12 23-24 1068 1075 18061887 1:CAS:528:DC%2BD2sXhsVSmurnF (Pubitemid 350186132)
17. AH Goldberg M Gibaldi JL Kanig M Myersohn 1966 Increasing dissolution rates and gastrointestinal absorption of drugs IV: chloramphenicol-urea system J Pharm Sci 55 6 581 583 5924122 1:CAS:528:DyaF28XksFKis74%3D
18. JY Hong JK Kim YK Song JS Park CK Kim 2006 A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption J Control Release 110 2 332 338 16297483 1:CAS:528:DC%2BD2MXhtlert7nM
19. M Fernandez-Tarrio F Yañez K Immesoete C Alvarez-Lorenzo A Concheiro 2008 Pluronic and tetronic copolymers with polyglycolyzed oils as self-emulsifying drug delivery systems AAPS PharmSciTech 9 2 471 479 18431654 1:CAS:528:DC%2BC3cXnslGjt7k%3D
20. B Tang G Cheng JC Gu CH Xu 2008 Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms Drug Discov Today 13 13-14 606 612 18598917 1:CAS:528:DC%2BD1cXotlClsr8%3D
21. Corrigan OI, Healy AM. Surfactants in pharmaceutical products and systems. In: Encyclopedia of pharmaceutical technology. New York: Marcel Dekker Inc.; 2002(3): pp. 2639-2653.
22. F Qian J Huang MA Hussain 2010 Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development J Pharm Sci 99 7 2941 2947 20127825 1:CAS:528:DC%2BC3cXlsVSku7Y%3D
23. Hancock BC, Shamblin SL, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res. 1995;12(6):799-806.
24. M-Y Heo Z-Z Piao T-W Kim Q-R Cao A Kim B-J Lee 2005 Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole Arch Pharm Res 28 5 604 611 15974450 1:CAS:528:DC%2BD2MXltVamtbw%3D (Pubitemid 44698739)
25. M Alden J Tegenfeldt ES Saers 1993 Structures formed by interactions in solid dispersions of the system polyethylene glycol-griseofulvin with charged and noncharged surfactants added Int J Pharm 94 1-3 31 38 1:CAS:528: DyaK3sXls1Olsb0%3D (Pubitemid 23204048)
26. Q-R Cao T-W Kim C-Y Choi K-A Kwon B-J Lee 2003 Preparation and dissolution of PVP-based solid dispersion capsules containing solubilizers J Korean Pharm Sci 33 1 7 14 1:CAS:528:DC%2BD3sXjt12htLk%3D
27. HN Joshi RW Tejwani M Davidovich VP Sahasrabudhe M Jemal MS Bathala, et al. 2004 Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture Int J Pharm 269 1 251 258 14698596 1:CAS:528:DC%2BD3sXpvFekur0%3D (Pubitemid 38032837)
28. T-W Kim C-Y Choi Q-R Cao K-A Kwon B-J Lee 2002 Dissolution profiles of solid dispersions containing poorly water-soluble drugs and solubilizing compositions J Korean Pharm Sci 32 3 191 197 1:CAS:528:DC%2BD3sXhsFyjs7g%3D
29. KR Morris GT Knipp ATM Serajuddin 1992 Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle J Pharm Sci 81 12 1185 1188 1491337 1:CAS:528:DyaK3sXksFKhug%3D%3D (Pubitemid 23018125)
30. PC Sheen VK Khetarpal CM Cariola CE Rowlings 1995 Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability Int J Pharm 118 2 221 227 1:CAS:528:DyaK2MXks1Kns70%3D
31. LH Emara RM Badr AA Elbary 2002 Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers Drug Dev Ind Pharm 28 7 795 807 12236065 1:CAS:528:DC%2BD38XmvFOgt74%3D (Pubitemid 34977797)
32. PH-L Tran HTT Tran B-J Lee 2008 Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release J Control Release 129 1 59 65 18501462 1:CAS:528: DC%2BD1cXmvVGjtL0%3D
33. TT-D Tran PH-L Tran B-J Lee 2009 Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug Eur J Pharm Biopharm 72 1 83 90 19141319 1:CAS:528:DC%2BD1MXjvVOqtLo%3D
34. TT-D Tran PH-L Tran H-G Choi H-K Han B-J Lee 2010 The roles of acidifiers in solid dispersions and physical mixtures Int J Pharm 384 1-2 60 66 19782736 1:CAS:528:DC%2BD1MXhsVyju7zK
35. PH-L Tran TT-D Tran K-H Lee D-J Kim B-J Lee 2010 Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility Expert Opin Drug Deliv 7 5 647 661 20205605 1:CAS:528:DC%2BC3cXltFSqur4%3D
36. S Takka S Rajbhandari A Sakr 2001 Effect of anionic polymers on the release rate of propronolol hydrochloride from matrix tablets Eur J Pharm Biopharm 52 1 75 82 11438426 1:CAS:528:DC%2BD3MXkvVeksLY%3D (Pubitemid 32594790)
37. CG Cameron JW McGinity 1987 Controlled release theophylline tablet formulations containing acrylic resins. II. Combination resin formulations Drug Dev Ind Pharm 13 8 1409 1427 1:CAS:528:DyaL2sXltVamt7Y%3D (Pubitemid 17145972)
38. GS Rekhi RV Nellore AS Hussain LG Tillman HJ Malinowski LL Augsburger 1999 Identification of critical formulation and processing variables for metoprolol tartarate extended release (ER) matrix tablets J Control Release 59 3 327 342 10332064 1:CAS:528:DyaK1MXjtVykurY%3D (Pubitemid 29238176)
39. MA Vandelli E Leo F Foni MT Bernabei 1998 Drug release from perforated matrices containing hydroxypropylcellulose Int J Pharm 171 2 165 175 1:CAS:528:DyaK1cXls1eqtbo%3D (Pubitemid 29023109)
40. Li X, Jasti BR. Design of controlled release drug delivery systems. Columbus: McGraw-Hill; 2005.
41. J Liu F Zhang JW McGinity 2001 Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion Eur J Pharm Biopharm 52 2 181 190 11522484 1:CAS:528:DC%2BD3MXmtV2ktLY%3D (Pubitemid 32755897)
42. Agrawal AM, Manek RV, Kolling WM, Neau SH. Studies on the interaction of water with ethylcellulose: Effect of polymer particle size. AAPS PharmSciTech. 2003;4(4): article 60.
43. Z Iqbal A Babar M Ashraf 2002 Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method Drug Dev Ind Pharm 28 2 129 134 11926356 1:CAS:528:DC%2BD38Xit1Kgurs%3D (Pubitemid 34218776)
44. Emeje MO, Kunle OO, Ofoefule SI. Compaction characteristics of ethylcellulose in the presence of some channeling agents: technical note. AAPS PharmSciTech. 2006;7(3): article 58. doi: 10.1208/pt070358.
45. Agrawal AM, Neau SH, Bonate PL. Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release. AAPS PharmSci. 2003;5(2): article 13. doi: 10.1208/ps050213.
46. SM Upadrashta PR Katikaneni GA Hileman PR Keshary 1993 Direct compression controlled release tablets using ethylcellulose matrices Drug Dev Ind Pharm 19 4 449 460 1:CAS:528:DyaK3sXitF2ksL0%3D (Pubitemid 23063377)
47. SH Neau MA Howard JS Claudius DR Howard 1999 The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets Int J Pharm 179 1 97 105 10053206 1:CAS:528:DyaK1MXhsVensLg%3D (Pubitemid 29115064)
48. DK Pollock PJ Sheskey 1996 Micronized ethylcellulose: opportunities in direct-compression controlled-release tablets Pharm Technol 20 9 120 130 1:CAS:528:DyaK28Xmtlyks7w%3D (Pubitemid 26323307)
49. SI Pather I Russell JA Syce SH Neau 1998 Sustained release theophylline tablets by direct compression. Part 1: formulation and in vitro testing Int J Pharm 164 1-2 1 10 1:CAS:528:DyaK1cXitlSrtr0%3D (Pubitemid 28160092)
50. PR Katikaneni SM Upadrashta SH Neau AK Mitra 1995 Ethylcellulose matrix controlled release tablets of a water-soluble drug Int J Pharm 123 1 119 125 1:CAS:528:DyaK2MXmvF2mur8%3D
51. KA Mehta MS Kislaloglu W Phuapradit AW Malick NH Shah 2001 Release performance of a poorly soluble drug from a novel Eudragit-based multi-unite erosion matrix Int J Pharm 213 1-2 7 12 11165089 1:CAS:528: DC%2BD3MXmvFKrtw%3D%3D (Pubitemid 32119457)
52. PC Wu YB Huang JS Chang MJ Tsai YH Tsai 2003 Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit® Eur J Pharm Sci 19 2-3 115 122 12791413 1:CAS:528:DC%2BD3sXkt1ymu7g%3D
53. Kibbe AH, Wade A, Weller PJ. Handbook of pharmaceutical excipients. Washington: American Pharmaceutical Association; 2000.
54. KG Wagner JW McGinity 2002 Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films J Control Release 82 2-3 385 397 12175751 1:CAS:528:DC%2BD38XlvFOrsr0%3D (Pubitemid 34880192)
55. R Bodmeier X Guo RE Sarabia PF Skultety 1996 The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D Pharm Res 13 1 52 56 8668678 1:CAS:528:DyaK28XhtFWqu7k%3D (Pubitemid 26076295)
56. B Glaessl F Siepmann I Tucker J Siepmann T Rades 2009 Characterisation of quaternary polymethacrylate films containing tartaric acid, metoprolol free base or metoprolol tartrate Eur J Pharm Biopharm 73 3 366 372 19651209 1:CAS:528:DC%2BD1MXhtlCntLbF
57. A Stamm JC Tritsch 1986 Some considerations on the liberation of drugs from inert matrices Drug Dev Ind Pharm 12 11-13 2337 2353 1:CAS:528: DyaL28Xmtlagt7s%3D (Pubitemid 17178877)
58. SN Makhija PR Vavia 2002 Once daily sustained release tablets of venlafaxine, a novel antidepressant Eur J Pharm Biopharm 54 1 9 15 12084497 1:CAS:528:DC%2BD38XkslKisb4%3D (Pubitemid 34663851)
59. CN Patra AB Kumar HK Pandit SP Singh MV Devi 2007 Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride Acta Pharm 57 4 479 489 18165191 1:CAS:528:DC%2BD1cXnsVyntQ%3D%3D
60. JM Acevez R Cruz E Hernandes 2000 Preparation and characterization of furosemide-Eudragit controlled-release systems Int J Pharm 195 1-2 45 53 (Pubitemid 30089489)
61. A Ceballos M Cirri F Maestrelli G Corti P Mura 2005 Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets Farmaco 60 11-12 913 918 16129436 1:CAS:528:DC%2BD2MXhtFyktrjE (Pubitemid 41586266)
62. F Siepmann K Eckart A Maschke K Kolter J Siepmann 2010 Modeling drug release from PVAc/PVP matrix tablets J Control Release 141 2 216 222 19737588 1:CAS:528:DC%2BD1MXhs1Slu7vK
63. K Kolter W Fraunhofer F Ruchatz 2001 Properties of Kollidon® SR as a new excipient for sustained release dosage forms BASF ExAct 6 5 7
64. MS Reza MA Quadir SS Haider 2003 Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery J Pharm Pharm Sci 6 2 274 291
65. Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmaSciTech. 2003;4(3): article 31. doi: 10.1208/pt040331.
66. R Bodmeier J Wang H Bhagwatwar 1992 Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs J Microencapsul 9 1 89 98 1613647 1:CAS:528:DyaK38XhsFyrsrY%3D
67. Y Miyagawa T Okabe Y Yamaguchi M Miyajima H Sato H Sunada 1996 Controlled-release of diclofenac sodium from wax matrix granule Int J Pharm 138 2 215 224 1:CAS:528:DyaK28XksF2nsbc%3D (Pubitemid 26281179)
68. N Passerini B Apertini 2002 Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation Eur J Pharm Sci 15 1 71 78 11803133 1:CAS:528:DC%2BD38Xms1Gmuw%3D%3D (Pubitemid 34136970)
69. D Saraiya S Bolton 1990 The use of precirol to prepare sustained release tablet of theophylline and quinidine gluconate Drug Dev Ind Pharm 16 13 1963 1969 1:CAS:528:DyaK3cXlslyiurY%3D (Pubitemid 20300935)
70. OL Sprockel M Sen P Shivanand W Prapaitrakul 1997 A melt extrusion processes for manufacturing matrix drug delivery systems Int J Pharm 155 2 191 199 1:CAS:528:DyaK2sXmsFGksLc%3D (Pubitemid 27380405)
71. M Savolainen C Khoo H Glad C Dahlqvist AM Juppo 2002 Evaluation of controlled-release polar lipid microparticles Int J Pharm 244 1-2 151 161 12204574 1:CAS:528:DC%2BD38XmsVahsrc%3D (Pubitemid 35245455)
72. S Malamataris A Panagopoulou P Hatzipantou 1991 Controlled release from glycerol palmito-stearate matrices prepared by dry-heat granulation and compression at elevated temperature Drug Dev Ind Pharm 17 13 1765 1777 1:CAS:528:DyaK3MXlvV2ltbY%3D
73. MRP Rao AA Ranpise KC Thanki SG Borate GN Parikh 2009 Effect of processing and sintering on controlled release wax matrix tablets of ketorolac tromethamine Indian J Pharm Sci 71 5 538 544 20502573
74. FQ Li JH Hu JX Deng H Su S Xu JY Liu 2006 In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets Int J Pharm 324 2 152 157 16837152 1:CAS:528:DC%2BD28XhtVOgu7%2FN (Pubitemid 44528916)
75. P Barthelemy JP Laforet N Farah J Joachim 1999 Compritol® 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formations Eur J Pharm Biopharm 47 1 87 90 10234531 1:CAS:528:DyaK1MXjtVOrs7Y%3D (Pubitemid 29137760)
76. Mitsubishi-Kagaku Foods Corporation. Ryoto® Sugar Ester Technical Information. Tokyo: Mitsubishi-Kagaku Foods Corporation; 2003.
77. JD Ntawukulilyayo C Demuynck JP Remon 1995 Microcrystalline cellulose-sucrose esters as tablet matrix forming agents Int J Pharm 121 2 205 210 1:CAS:528:DyaK2MXmtVymur0%3D
78. K Chansanroj G Betz 2010 Sucrose esters with various hydrophilic- lipophilic properties: Novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction Acta Biomater 6 8 3101 3109 20132913 1:CAS:528:DC%2BC3cXpslOrt74%3D
79. HI Friedman B Nylund 1980 Intestinal fat digestion, absorption, and transport. A review Am J Clin Nutr 33 5 1108 1139 6989228 1:CAS:528: DyaL3cXktVCmsrw%3D (Pubitemid 10040647)
80. CJH Porter NL Trevaskis WN Charman 2007 Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat Rev Drug Discov 6 231 248 17330072 1:CAS:528:DC%2BD2sXit12rsbY%3D (Pubitemid 46344627)
81. T Shigeoka O Izawa K Kitazawa F Yamauchi 1984 Studies on the metabolic fate of sucrose esters in rats Food Chem Toxicol 22 6 409 414 6539729 1:CAS:528:DyaL2cXks12qtLg%3D (Pubitemid 14119167)
82. DA Alderman 1984 A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms Int J Pharm Tech Prod Manuf 5 3 1 9 1:CAS:528:DyaL2MXksVantrw%3D (Pubitemid 15105124)
83. N Peppas 1985 Analysis of Fickian and non-Fickian drug release from polymers Pharm Acta Helv 60 4 110 111 4011621 1:CAS:528:DyaL2MXktFWgtb8%3D
84. TD Reynolds SA Mitchell KM Balwinski 2002 Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets Drug Dev Ind Pharm 28 4 457 466 12056539 1:CAS:528:DC%2BD38XktFCkurs%3D (Pubitemid 34547882)
85. MJ Vazquez B Perez-Marcos JL Gomez-Amoza R Martinez-Pacheco C Souto A Concheiro 1992 Influence of technological variables on release of drugs from hydrophilic matrices Drug Dev Ind Pharm 18 11-12 1355 1375 1:CAS:528: DyaK38XkvFOisbg%3D
86. P Sriamornsak N Thirawong K Korkerd 2007 Swelling, erosion and release behavior of alginate-based matrix tablets Eur J Pharm Biopharm 66 3 435 450 17267187 1:CAS:528:DC%2BD2sXlsFKmtbY%3D (Pubitemid 46756227)
87. JW Skoug MV Mikelsons CN Vigneron NL Stemm 1993 Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release J Control Release 27 3 227 245 1:CAS:528:DyaK2cXos1aruw%3D%3D (Pubitemid 24015725)
88. P Gao JW Skoug PR Nixon TR Ju NL Stemm K-C Sung 1996 Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of influence of formulation variables on matrix performance and drug release J Pharm Sci 85 7 732 740 8818998 1:CAS:528:DyaK28XjsVahtr8%3D (Pubitemid 26234678)
89. SK Kundu M Yoshida M Shibayama 2010 Effect of salt content on the rheological properties of hydrogel based on oligomeric electrolyte J Phys Chem B 114 4 1541 1547 20055469 1:CAS:528:DC%2BC3cXivFKntA%3D%3D
90. Jain KK. Drug delivery systems. Totowa: Humana Press; 2008.
91. Cui SW. Food carbohydrates: chemistry, physical properties, and applications. Portland: CRC; 2005.
92. N Sarkar 1995 Kinetics of thermal gelation of methylcellulose and hydroxypropylmethylcellulose in aqueous solutions Carbohydr Polym 26 3 195 203 1:CAS:528:DyaK2MXlvFars78%3D
93. K Mitchell JL Ford DJ Armstrong PNC Elliott JE Hogan C Rostron 1993 The influence of substitution type on the performance of methylcellulose and hydroxypropylmethylcellulose in gels and matrices Int J Pharm 100 1-3 143 154 1:CAS:528:DyaK2cXjsl2rtQ%3D%3D (Pubitemid 23316326)
94. K Mitchell JL Ford DJ Armstrong PNC Elliott JE Hogan C Rostron 1993 The influence of the particle size of hydroxypropylmethylcellulose K15M on its hydration and performance in matrix tablets Int J Pharm 100 1-3 175 179 1:CAS:528:DyaK2cXjsl2qsg%3D%3D (Pubitemid 23316329)
95. Scott CT. Pulp extrusion at ultra-high consistencies: Selection of watersoluble polymers for process optimization. In: Proceedings of the 2002 TAPPI fall technical conference and trade fair. San Diego, CA. Atlanta, GA: TAPPI press. 2002; 105-114.
96. J Bajdik G Baki A Kelemen K Pintye-Hodi 2008 The effect of wetting of powder mixture on the preparation of hydrophilic matrix granules with high-shear granulator Chem Eng Res Des 86 1 1 7 1:CAS:528:DC%2BD1cXjvFeiu7w%3D (Pubitemid 351722795)
97. S Baumgartner J Kristl NA Peppas 2002 Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium Pharm Res 19 8 1084 1090 12240932 1:CAS:528:DC%2BD38XmtlGhurk%3D (Pubitemid 34984990)
98. A Viridén A Larsson B Wittgren 2010 The effect of substitution pattern of HPMC on polymer release from matrix tablets Int J Pharm 389 1-2 147 156 20100556
99. A Viridén B Wittgren T Andersson S Abrahmsén-Alami A Larsson 2009 Influence of substitution pattern on solution behavior of hydroxypropyl methylcellulose Biomacromolecules 10 3 522 529 19173653
100. SD Bhat TM Aminabhavi 2007 Pervaporation separation using sodium alginate and its modified membranes-A review Sep Purif Rev 36 3 203 229 1:CAS:528:DC%2BD2sXpslaqtrk%3D (Pubitemid 47347263)
101. Sriamornsak P, Sungthongjeen S. Modification of theophylline release with alginate gel formed in hard capsules. AAPS PharmSciTech. 2007;8(3). doi: 10.1208/pt0803051.
102. R Tan Q Feng Z She M Wang H Jin J Li, et al. 2010 In vitro and in vivo degradation of an injectable bone repair composite Polym Degrad Stab 95 9 1736 1742 1:CAS:528:DC%2BC3cXpvFeiu74%3D
103. T Boontheekul HJ Kong DJ Mooney 2005 Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution Biomaterials 26 15 2455 2465 15585248 1:CAS:528:DC%2BD2cXhtVCiu7fP (Pubitemid 39600698)
104. S Miyazaki W Kubo D Attwood 2000 Oral sustained delivery of theophylline using in si-tu gelation of sodium alginate J Control Release 67 2-3 275 280 10825560 1:CAS:528:DC%2BD3cXjsVegtrs%3D (Pubitemid 30303841)
105. KI Draget GS Bræk O Smidsrød 1994 Alginic acid gels: the effect of alginate chemical composition and molecular weight Carbohydr Polym 25 1 31 38 1:CAS:528:DyaK2MXisFynsb4%3D
106. AC Hodsdon JR Mitchell MC Davies CD Melia 1995 Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices J Control Release 33 1 143 152 1:CAS:528:DyaK2MXjt1SrtLs%3D
107. P Timmins AM Delargy CM Minchom JR Howard 1992 Influence of some process variables on product properties for a hydrophilic matrix controlled release tablet Eur J Pharm Biopharm 38 3 113 118 1:CAS:528:DyaK3sXhslGltb0%3D
108. Ø; Holte E Onsøyen R Myrvold J Karlsen 2003 Sustained release of water-soluble drug from directly compressed alginate tablets Eur J Pharm Sci 20 4-5 403 407 14659484 1:CAS:528:DC%2BD3sXptlynurk%3D (Pubitemid 37492992)
109. T Sirkiä H Salonen P Veski H Jürjenson M Marvola 1994 Biopharmaceutical evaluation of new prolonged-release press-coated ibuprofen tablets containing sodium alginate to adjust drug release Int J Pharm 107 3 179 187
110. MA Bayomi SA Al-Suwayeh A-RM El-Helw 2001 Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation Drug Dev Ind Pharm 27 6 499 506 11548856 1:CAS:528: DC%2BD3MXmslSrs7Y%3D (Pubitemid 32803568)
111. K Kaneko K Kanada T Yamada M Miyagi N Saito T Ozeki, et al. 1998 Formation of water-insoluble gel in dry coated tablets for the controlled release of theophylline Chem Pharm Bull 46 4 728 729 9579051 1:CAS:528:DyaK1cXisl2mu70%3D (Pubitemid 28216959)
112. K Kaneko K Kanada T Yamada M Miyagi N Saito T Ozeki, et al. 1997 Application of gel formation for taste masking Chem Pharm Bull 45 6 1063 1068 1:CAS:528:DyaK2sXkt1Ogs7k%3D (Pubitemid 27291352)
113. CV Liew LW Chan AL Ching PSW Heng 2006 Evaluation of sodium alginate as drug release modifier in matrix tablets Int J Pharm 309 1-2 25 37 16364576 1:CAS:528:DC%2BD28XnvVWnsQ%3D%3D (Pubitemid 43129461)
114. MM Talukdar A Michoel P Rombaut R Kinget 1996 Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behavior Int J Pharm 129 1-2 233 241 1:CAS:528:DyaK28XitVSqs78%3D (Pubitemid 26098739)
115. MM Talukdar R Kinget 1995 Swelling and drug release behavior of xanthan gum matrix tablets Int J Pharm 120 1 63 72 1:CAS:528:DyaK2MXltl2it7s%3D
116. J Sujja-areevath DL Munday PJ Cox KA Khan 1998 Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations Eur J Pharm Sci 6 3 207 217 9795062 1:CAS:528:DyaK1cXjt1CmtrY%3D (Pubitemid 28473221)
117. M Singlga A Chawla A Singh 2000 Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review Drug Dev Ind Pharm 26 9 913 924 (Pubitemid 30471037)
118. HS Park MK Chun HK Choi 2008 Preparation of an extended-release matrix tablet using chitosan/carbopol interpolymer complex Int J Pharm 347 1-2 39 44 17662544 1:CAS:528:DC%2BD2sXhtlOjsrnJ
119. B Kriwet T Kissel 1996 Interactions between bioadhesive poly(acrylic acid) and calcium ions Int J Pharm 127 2 135 145 1:CAS:528:DyaK28Xhslegt7s%3D (Pubitemid 26092132)
120. H Hagerstrom M Paulsson K Edsman 2000 Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method Eur J Pharm Sci 9 3 301 309 10594388 1:CAS:528:DyaK1MXnslGrsb4%3D
121. F Veiga T Salsa ME Pina 1998 Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices Drug Dev Ind Pharm 24 1 1 9 15605591 1:CAS:528:DyaK1cXhtVymu70%3D (Pubitemid 28080832)
122. A Apicella B Cappello MAD Nobile MIL Rotonda G Mensitieri L Nicolais 1993 Poly(Ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release Biomaterials 14 2 83 90 8435462 1:CAS:528: DyaK3sXhslGlt7Y%3D (Pubitemid 23072680)
123. CJ Kim 1995 Drug release from compressed hydrophilic polyox-WSR Tablets J Pharm Sci 84 3 303 306 7616368 1:CAS:528:DyaK2MXjvVSkt7s%3D
124. CJ Kim 1998 Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets Drug Dev Ind Pharm 24 7 645 651 9876509 1:CAS:528:DyaK1cXktFOiur4%3D
125. Y Xie P Xie X Song X Tang H Song 2008 Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics Int J Pharm 360 1-2 53 57 18495389 1:CAS:528:DC%2BD1cXos12ms7g%3D
126. R Tiwari G Tiwari S Srivastava AK Rai 2009 Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs Int J PharmTech Res. 1 4 1338 1349 1:CAS:528:DC%2BD1MXhsVWkt7zE
127. M Fernández IC Rodríguez MV Margarit A Cerezo 1992 Characterization of solid dispersions of piroxicam/poly(ethylene glycol) 4000 Int J Pharm 84 2 197 202
128. J Desai K Alexander A Riga 2006 Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release Int J Pharm 308 1-2 115 123 16326055 1:CAS:528:DC%2BD28Xls1Srsg%3D%3D (Pubitemid 43097242)
129. HN Shivakumar BG Desai G Deshmukh 2008 Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology Ind J Pharm Sci 70 1 22 30 1:STN:280:DC%2BC3c3mtVOjtQ%3D%3D (Pubitemid 351670564)
130. T Ozeki H Yuasa Y Kanaya K Oishi 1995 Application of the solid dispersion method to the controlled release of medicine. VII. Release mechanism of a highly water-soluble medicine from solid dispersion with different molecular weight of polymer Chem Pharm Bull 43 4 660 665 1:CAS:528:DyaK2MXnsVWntbc%3D
131. PD Filippis G Zingone M Gibellini F Rubessa P Rupena 1995 Dissolution rates of different drugs from solid dispersions with Eudragit RS Eur J Pharm Sci 3 5 265 271
132. SA Patil BS Kuchekar AR Chabukswar SC Jagdale 2010 Formulation and evaluation of extended-release solid dispersion of metformin hydrochloride J Young Pharm. 2 2 121 129 21264113 1:CAS:528:DC%2BC3cXhtFOns7vE
133. M Lovrecich F Nobile F Rubessa G Zingone 1996 Effect of ageing on the release of indomethacin from solid dispersions with Eudragit Int J Pharm 131 2 247 255 1:CAS:528:DyaK28XjtFSksLs%3D (Pubitemid 26143842)
134. MK Gupta RH Bogner D Goldman YC Tseng 2002 Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage Pharm Dev Technol 7 1 103 112 11852693 1:CAS:528:DC%2BD38Xht1Ohtrw%3D (Pubitemid 35154420)
135. H Konno T Handa DE Alonzo LS Taylor 2008 Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine Eur J Pharm Biopharm 70 2 493 499 18577451 1:CAS:528:DC%2BD1cXhtFOmtbnE
136. T Ohara S Kitamura T Kitagawa K Terada 2005 Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose Int J Pharm 302 1-2 95 102 16102924 1:CAS:528:DC%2BD2MXpvVWis7w%3D (Pubitemid 41242755)
137. RP Dixit MS Nagarsenkar 2007 In vitro and in vivo advantage of celecoxib surface solid dispersion and dosage form development Ind J Pharm Sci 69 3 370 377 1:CAS:528:DC%2BD1MXhtVGqs7fP
138. KA Coppens MJ Hall SA Mitchell MD Read 2006 Hypromellose, ethylcellulose, and polyethylene oxide use in hot melt extrusion (cover story) Pharm Technol 30 1 62 70 1:CAS:528:DC%2BD28XhtFCgsbk%3D (Pubitemid 43139760)
139. R Chokshi H Zia 2004 Hot-melt extrusion technique: a review IJPR 3 1 3 16
140. CR Young JJ Koleng JW McGinity 2002 Production of spherical pellets by a hot-melt extrusion and spheronization process Int J Pharm 242 1-2 87 92 12176229 1:CAS:528:DC%2BD38Xmt1ygurY%3D
141. MM Crowley B Schroeder A Fredersdorf S Obara M Talarico S Kucera, et al. 2004 Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion Int J Pharm 269 2 509 522 14706261 1:CAS:528:DC%2BD3sXhtVWjsr3J (Pubitemid 38045312)
142. McGinity JW, Zhang F. Melt-extruded controlled-release dosage forms. In: Ghebre-Sellassie I, Martin C, editors. Pharmaceutical extrusion technology. New York: Marcel Dekker. 2003; 133: 183-208.
143. M Ozawa K Hasegawa Y Yonezawa H Sunada 2002 Preparation of solid dispersion for ethenzamide-carbopol and theophylline-carbopol systems using a twin screw extruder Chem Pharm Bull 50 6 802 807 12045335 1:CAS:528: DC%2BD38XkvFOlt7k%3D (Pubitemid 41694898)
144. K Nakamichi H Yasuura H Fukui 1996 Preparation of nifedipine- hydroxypropylmethylcellulose phthalate solid dispersion by twin screw extruder and its evaluation J Pharm Sci Technol Jpn 56 1 15 22 1:CAS:528: DyaK28Xjt1Oitr0%3D
145. H Sato Y Miyagawa T Okabe M Miyajima H Sunada 1997 Dissolution mechanism of diclofenac sodium from wax matrix granules J Pharm Sci 86 8 929 934 9269871 1:CAS:528:DyaK2sXksVeitrg%3D (Pubitemid 27344051)
146. K Nakamichi T Nakano H Yasuura S Izumi Y Kawashima 2002 The role of the kneading paddle and the effects of screw revolution speed and water content on the preparation of solid dispersions using a twin-screw extruder Int J Pharm 241 2 203 211 12100848 1:CAS:528:DC%2BD38XkvFeltr8%3D (Pubitemid 34718022)
147. Holm P, Buur A, Elema MO, Mollgaard B, Holm JE, Schultz K. Controlled agglomeration. United States Patent 7,217,431. US Patent and Trademark Office. May 15, 2007.
148. Y Kawashima T Niwa T Handa H Takeuchi T Iwamoto K Itoh 1989 Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method J Pharm Sci 78 1 68 72 2709323 1:CAS:528:DyaL1MXhtVWlu7s%3D (Pubitemid 19079816)
149. F Cui M Yang Y Jiang D Cun W Lin Y Fan, et al. 2003 Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method J Control Release 91 3 375 384 12932715 1:CAS:528:DC%2BD3sXmsVSrsbY%3D (Pubitemid 36976768)
150. M Yang F Cui B You Y Fan L Wang P Yue, et al. 2003 Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method Int J Pharm 259 1-2 103 113 12787640 1:CAS:528:DC%2BD3sXktF2rt78%3D (Pubitemid 36638558)
151. R Hu J Zhu G Chen Y Sun K Mei S Li 2006 Preparation of sustained-release simvastatin microspheres by the spherical crystallization technique Asian J Pharm Sci 1 1 47 52 1:CAS:528:DC%2BD1cXhtFKgur0%3D
152. DB Beten K Amighi AJ Moes 1995 Preparation of controlled-release coevaporates of dipyridamole by loading neutral pellets in a fluidized-bed coating system Pharm Res 12 9 1269 1272 8570519 1:CAS:528:DyaK2MXpslOit7g%3D
153. H Ho HL Su T Tsai MT Sheu 1996 The preparation and characterization of solid dispersions on pellets using a fluidized bed system Int J Pharm 139 1-2 223 229 1:CAS:528:DyaK28XkvFWgu78%3D (Pubitemid 26276286)
154. Gilis PA, De Conde V, Vandecruys R. Beads having a core coated with an antifungal and a polymer. US patent 5,633,015. 1997.
155. G Yan H Li R Zhang D Ding 2000 Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets Drug Dev Ind Pharm 26 6 681 686 10826117 1:CAS:528:DC%2BD3cXjt1Cjsb0%3D (Pubitemid 30317075)
156. Klokkers K. Solid, non-deliquescent formulations of sodium valproate. US Patent 6204255. 2001.
157. BS Rathinaraj C Rajveer PK Choudhury G Sheshrao GV Shinde 2010 Studies on dissolution behavior of sustained release solid dispersion of nimodipine Int J Pharm Sci Rev Res 3 1 77 82 1:CAS:528:DC%2BC3cXovVegsL8%3D
158. H Chen G Jiang F Ding 2009 Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin Drug Dev Ind Pharm 35 2 131 137 19169941 1:CAS:528:DC%2BD1MXpsFyitw%3D%3D
159. Kigoshi M, Masada T, Ueno Y, Ishikawa Y, Hayakawa E. Solid dispersion dosage form of amorphous xanthine derivative and enteric-coating polymer. US Patent 6254889. 2001.
160. Fischer G, Bar-Shalom D, Slot L, Lademann A-M, Jensen C. Controlled release solid dispersions. WO/2003/024426. 2003.
161. A Zeng B Yuan Q Fu C Wang G Zhao 2009 Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug Pharm Dev Technol 14 5 499 505 19743948 1:CAS:528:DC%2BD1MXhtFWhu77K
162. LSC Wan PWS Heng LF Wong 1993 Relationship between swelling and drug release in a hydrophilic matrix Drug Dev Ind Pharm 19 10 1201 1210 1:CAS:528:DyaK3sXis1Srtbc%3D (Pubitemid 23130427)
163. P Colombo R Bettini NA Peppas 1999 Observation of swelling process and diffusion front position during swelling in hydroxypropyl methylcellulose (HPMC) matrices containing a soluble drug J Control Release 61 1-2 83 91 10469905 1:CAS:528:DyaK1MXlsFOku7s%3D (Pubitemid 29406082)
164. AR Rajabi-Siahboomi RW Bowtell P Mansfield A Henderson MC Davies CD Melia 1994 Structure and behaviour in hydrophilic matrix sustained release dosage forms: 2. NMR-imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration J Control Release 31 2 121 128 1:CAS:528:DyaK2cXlvVKqurw%3D (Pubitemid 24268158)
165. CA Fyfe AI Blazek 1997 Investigation of hydrogel formation from hydroxypropylmethylcellulose (HPMC) by NMR spectroscopy and NMR imaging techniques Macromolecules 30 20 6230 6237 1:CAS:528:DyaK2sXmtVemsrw%3D (Pubitemid 127574394)
166. TM Hyde LF Gladden 1998 Simultaneous measurement of water and polymer concentration profiles during swelling of poly(ethylene oxide) using magnetic resonance imaging Polymer 39 4 811 819 1:CAS:528:DyaK1cXktFCjug%3D%3D (Pubitemid 128397435)
167. J Tritt-Goc N Piślewski 2002 Magnetic resonance imaging study of the swelling kinetics of hydroxypropylmethylcellulose (HPMC) in water J Control Release 80 1-3 79 86 11943389 1:CAS:528:DC%2BD38XisFyrsL4%3D (Pubitemid 34273750)
168. S Baumgartner G Lahajnar A Sepe J Kristl 2005 Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods Eur J Pharm Biopharm 59 2 299 306 15661502 1:CAS:528:DC%2BD2MXmtlGjuw%3D%3D (Pubitemid 40127587)
169. CA Fyfe AI Blazek-Welsh 2000 Quantitative NMR imaging study of the mechanism of drug release from swelling hydroxypropylmethylcellulose tablets J Control Release 68 3 313 333 10974386 1:CAS:528:DC%2BD3cXmtFGktLc%3D
170. C Dahlberg A Fureby M Schuleit SV Dvinskikh I Furó 2007 Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study J Control Release 122 2 199 205 17706829 1:CAS:528: DC%2BD2sXhtVSktbbP (Pubitemid 47361408)
171. Borst I, Ugwu S, Beckett AH. New and extended application for USP drug release apparatus 3. Dissolut Technol. 1997; 1-6.
172. RK Kar S Mohapatra BB Barik 2009 Design and characterization of controlled release matrix tablets of zidovudine Asian J Pharm Clin Res 2 2 54 61 1:CAS:528:DC%2BC3cXktl2qsrY%3D
173. K Thoma I Ziegler 1998 Simultaneous quantification of released succinic acid and a weakly basic drug compound in dissolution media Eur J Pharm Biopharm 46 2 183 190 9795052 1:CAS:528:DyaK1cXnsFKhtb0%3D (Pubitemid 28414477)
174. A Streubel J Siepmann A Dashevsky R Bodmeier 2000 pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets J Control Release 67 1 101 110 10773333 1:CAS:528:DC%2BD3cXisV2nt7w%3D (Pubitemid 30201685)
175. H Kranz C Guthmannb T Wagner R Lipp J Reinhard 2005 Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug Eur J Pharm Sci 26 1 47 53 15953712 1:CAS:528:DC%2BD2MXntVGjsrc%3D (Pubitemid 41097260)
176. S Siepe B Lueckel A Krammer A Ries R Gurny 2006 Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH Int J Pharm 316 1-2 14 20 16551495 1:CAS:528:DC%2BD28XkvVWrsb4%3D (Pubitemid 44226313)
177. C Doherty P York 1989 Microenvironmental pH control of drug dissolution Int J Pharm 50 3 223 232 1:CAS:528:DyaL1MXhsl2nsr4%3D
178. ATM Serajuddin CI Jarowski 1985 Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts II: salicylic acid, Theophylline, and Benzoic acid J Pharm Sci 74 2 148 154 3989683 1:CAS:528:DyaL2MXhvFSqtrg%3D (Pubitemid 15135800)
179. M Pudipeddi EA Zannou M Vasanthavada A Dontabhaktuni AE Royce YM Joshi, et al. 2008 Measurement of surface pH of pharmaceutical solids: a critical evaluation of indicator dye-sorption method and its comparison with slurry pH method J Pharm Sci 97 5 1831 1842 17879289 1:CAS:528:DC%2BD1cXltlemsrw%3D
180. S Siepe W Herrmann HH Borchert B Lueckel A Kramer A Ries, et al. 2006 Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study J Control Release 112 1 72 78 16476499 1:CAS:528: DC%2BD28XjsFarsLY%3D
181. SJ Cope S Hibberd J Whetstone RJ Macrae CD Melia 2002 Measurement and mapping of pH in hydrating pharmaceutical pellets using confocal laser scanning microscopy Pharm Res 19 10 1554 1563 12425476 1:CAS:528:DC%2BD38XnsFSgtrg%3D (Pubitemid 35266563)
182. MP Oth AJ Moës 1989 Sustained release solid dispersions of indomethacin with Eudragit RS and RL Int J Pharm 55 2-3 157 164 1:CAS:528:DyaL1MXmtF2hsbw%3D (Pubitemid 19253786)
183. J Varshosaz H Faghihian K Rastgoo 2006 Preparation and characterization of metoprolol controlled-release solid dispersions Drug Deliv 13 4 295 302 16766471 1:CAS:528:DC%2BD28Xkt1Khs7s%3D (Pubitemid 43739141)
184. G Tiwari R Tiwari B Srivastava AK Rai 2008 Development and optimization of multi-unit solid dispersion systems of poorly water soluble drug Research J Pharm Tech. 1 4 444 449 1:CAS:528:DC%2BD1MXhtVOmurfN
185. S Nazzal MA Khan 2006 Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters Int J Pharm 315 1-2 110 121 16563673 1:CAS:528:DC%2BD28XksFyiu78%3D (Pubitemid 43674113)
186. NH Shah MT Carvajal CI Patel MH Infeld AW Malick 1994 Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int J Pharm 106 1 15 23 1:CAS:528:DyaK2cXjtlSqu74%3D (Pubitemid 24110060)
187. DQM Craig SA Barker D Banning SW Booth 1995 An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy Int J Pharm 114 1 103 110 1:CAS:528:DyaK2MXivVKrtrk%3D (Pubitemid 24377034)
188. PP Constantinides 1995 Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm Res 12 11 1561 1572 8592652 1:CAS:528:DyaK2MXpslCqsrs%3D (Pubitemid 26005509)
189. NR Gursoy S Benita 2004 Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed Pharmacother 58 3 173 182 15082340 (Pubitemid 38479922)